


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+7.57%
+0.81%
+54.71%
+5.33%
+0.11%
IVVD
Invivyd
$2.82
Strengths

Upgraded on attractively valued
IVVD Price Performance
$2.4 (+17.50%)
$1.12 (+151.79%)
$0.73 (+286.30%)
$0.51 (+452.94%)
IVVD has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

High volatilty

IVVD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
IVVD Analysts opinion is negative and has getting worse from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IVVD Street Sentiment is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels
What is IVVD current stock price?
What are IVVD stock strengths?
What is IVVD Risk Level?
What is IVVD market cap and volume?
What is IVVD current Stock IQ?
Should I buy IVVD stock right now?
Is IVVD a Strong Buy right now?
What does a 'Strong Buy' rating mean for IVVD?
What does a 'Strong Sell' rating mean for IVVD?
What factors influence IVVD's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+7.57%
+0.81%
+54.71%
+5.33%
+0.11%
IVVD
Invivyd
Current Price
$2.82
Stock Insights
Strengths

Upgraded on attractively valued

IVVD Price Performance
$2.4 (+17.50%)
$1.12 (+151.79%)
$0.73 (+286.30%)
$0.51 (+452.94%)
IVVD Analysts Opinion
IVVD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
IVVD Analysts opinion is negative and has getting worse from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IVVD Street Sentiment is unimpressive and have negative views on the near-term outlook
IVVD has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

High volatilty

Average key support and resistance price levels
IVVD Stock IQ
IVVD Latest Analysis
Invivyd Advances VYD2311 With Phase 3 Trial Launch And Fast Track Status . (RTTNews) - Invivyd Inc. (IVVD) has advanced its COVID-19 prevention portfolio with the launch of its pivotal Phase 3 DECLARATION trial of VYD2311 an investigational monoclonal antibody alongside securing Fast Track designation from the United States FDA.
Today
Invivyd granted FDA fast track status for COVID therapy.
Today
Invivyd stock rises after FDA grants Fast Track designation for COVID antibody.
Today
Invivyds COVID-19 Vaccine-Alternative Antibody VYD2311 Granted FDA Fast Track Status . (RTTNews) - Invivyd Inc. (IVVD) on Tuesday said the United States Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311 the companys vaccine-alternative antibody candidate to prevent COVID-19.
Today
BTIG Initiates Coverage of Invivyd (IVVD) with Buy Recommendation. Fintel reports that on December 22 2025 BTIG initiated coverage of Invivyd (NasdaqGM:IVVD) with a Buy recommendation. Analyst Price Forecast Suggests 225.22% Upside
Mon Dec 22, 2025
Invivyd Inc. (IVVD): Advancing RSV Antibody VBY329 Amid Analyst Downgrade. Invivyd Inc. (NASDAQ:IVVD) is one of the best multibagger penny stocks to buy right now. On November 24 the company selected VBY329 as a monoclonal antibody candidate for the prevention of Respiratory Syncytial Virus (RSV) in neonates infants and children. The company generated the investigational antibody from its proprietary antibody discovery technology for use in [….]
Thu Dec 18, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
IVVD Stock trends
IVVD Stock performance
IVVD Stock analysis
IVVD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.